NCT00660426 Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors Status COMPLETED Phase PHASE1
NCT00647530 Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery Status UNKNOWN Phase PHASE2/PHASE3
NCT00642746 Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC) Status TERMINATED Phase PHASE2
NCT00642603 A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00640081 Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00634751 CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT00627432 Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer Status COMPLETED Phase PHASE2
NCT00625183 Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma Status TERMINATED Phase PHASE2
NCT00625092 Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies Status COMPLETED Phase PHASE1
NCT00623805 A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00613080 Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE2
NCT00612677 Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem Status TERMINATED Phase PHASE2
NCT00610948 Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment Status COMPLETED Phase PHASE1
NCT00602602 Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00602329 MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00601705 Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach Status COMPLETED Phase PHASE2
NCT00591149 Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer Status TERMINATED Phase PHASE2
NCT00585078 Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE2
NCT00578071 Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer Status COMPLETED Phase PHASE1/PHASE2